Literature DB >> 15212865

Association of hospital resource use with comorbidity status and patient age among hip fracture patients in Japan.

Tatsuro Ishizaki1, Yuichi Imanaka, Eunhwan Oh, Kazuaki Kuwabara, Masahiro Hirose, Kenshi Hayashida, Yoshiaki Harada.   

Abstract

OBJECTIVES: This study examined the association of resource use with comorbidity status and patient age among hip fracture patients who underwent surgical treatment.
DESIGN: We used a database from the Voluntary Hospitals of Japan Quality Indicator Project that involved 10 privately owned leading teaching hospitals in Japan.
SETTING: Four of these hospitals in Japan. PARTICIPANTS: We selected 778 operable hip fracture patients aged 65 or older who were admitted to these hospitals between January 1996 and August 2000 (mean age: 80.3 +/- 7.3 years). MEASUREMENTS: A linear mixed model was performed to identify factors associated with the resource use, such as total length of stay (LOS), LOS before surgery, LOS after surgery, total hospital charges, charges for diagnostic examinations, charges for surgery, and length of theater time, among operable hip fracture patients.
RESULTS: The mean LOS was 45.9 days, and the mean total hospital charges were US dollars 14,495.0. Results from linear mixed models revealed that higher age was significantly associated with shorter length of theater time (P < 0.01), and that the presence of comorbidity among hip fracture patients was significantly associated with longer total LOS (P < 0.01), longer LOS after surgery (P < 0.001), higher charges for diagnostic examinations (P < 0.001), and shorter length of theater time (P < 0.01).
CONCLUSION: These results suggest that the presence of comorbidity among operable hip fracture patients requires greater resource use during their hospital stay, but higher age is not significantly associated with greater resource use at all.

Entities:  

Mesh:

Year:  2004        PMID: 15212865     DOI: 10.1016/j.healthpol.2003.12.018

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  7 in total

1.  Emergency department census of patients awaiting admission following reorganisation of an admissions process.

Authors:  E D Moloney; K Bennett; D O'Riordan; B Silke
Journal:  Emerg Med J       Date:  2006-05       Impact factor: 2.740

Review 2.  Economic burden of osteoporosis-related hip fracture in Asia: a systematic review.

Authors:  N-A Mohd-Tahir; S-C Li
Journal:  Osteoporos Int       Date:  2017-03-17       Impact factor: 4.507

3.  Do consultants differ? Inferences drawn from hospital in-patient enquiry (HIPE) discharge coding at an Irish teaching hospital.

Authors:  E D Moloney; D Smith; K Bennett; D O'Riordan; B Silke
Journal:  Postgrad Med J       Date:  2005-05       Impact factor: 2.401

4.  Impact of treatment policies on patient outcomes and resource utilization in acute cholecystitis in Japanese hospitals.

Authors:  Miho Sekimoto; Yuichi Imanaka; Masahiro Hirose; Tatsuro Ishizaki; Genki Murakami; Yushi Fukata
Journal:  BMC Health Serv Res       Date:  2006-03-29       Impact factor: 2.655

5.  Medical expenditures for fragility hip fracture in Japan: a study using the nationwide health insurance claims database.

Authors:  Takahiro Mori; Jun Komiyama; Tomoko Fujii; Masaru Sanuki; Keitaro Kume; Genta Kato; Yukiko Mori; Hiroaki Ueshima; Hiroki Matsui; Nanako Tamiya; Takehiro Sugiyama
Journal:  Arch Osteoporos       Date:  2022-04-11       Impact factor: 2.617

6.  The Role of Autobiographical Story-Telling During Rehabilitation Among Hip-Fracture Geriatric Patients.

Authors:  Paola Iannello; Federica Biassoni; Laura Bertola; Alessandro Antonietti; Valerio Antonello Caserta; Lorenzo Panella
Journal:  Eur J Psychol       Date:  2018-06-19

7.  Estimated expenditures for hip fractures using merged healthcare insurance data for individuals aged ≥ 75 years and long-term care insurance claims data in Japan.

Authors:  Takahiro Mori; Nanako Tamiya; Xueying Jin; Boyoung Jeon; Satoru Yoshie; Katsuya Iijima; Tatsuro Ishizaki
Journal:  Arch Osteoporos       Date:  2018-03-30       Impact factor: 2.617

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.